期刊文献+

中枢神经兴奋剂莫达非尼在大鼠体内的药动学 被引量:2

Study on pharmacoknetics of modafinil in rat
下载PDF
导出
摘要 目的 :研究SD大鼠单剂量口服莫达非尼后 ,莫达非尼在大鼠体内的药动学特征。方法 :SD大鼠单剂量 4 .0mg·kg-1 灌胃莫达非尼混悬液 ,于各时间点 ,心脏取血 ,分离血清 ,用高效液相色谱法测定莫达非尼的浓度 ,所得血药浓度 时间数据用 3P87药动学软件处理 ,求得药动学参数。结果 :莫达非尼药 时曲线符合二室模型 ,T1 /2α为 (0 .4 8± 0 .0 9)h ,T1 /2 β为(3.5 5± 0 .2 7)h ,Tmax为 (0 .79± 0 .0 6 )h ,Cmax为 (3.5 3± 0 .0 5 )mg·L-1 ,AUC0~∞ 为 (1 4 .32± 0 .30 )mg·h·L-1 。结论 :莫达非尼在大鼠体内分布较快 ,消除较慢 ,具有良好的药代动力学特征。 OBJECTIVE To study the pharmacokinetics behavior of modafinil in rat.METHODS The concentration of modafinil in serum was determined by HPLC following a single oral dose. The pharmacokinetics parameters were fitted by 3P87 program. The steady state concentrations of modafinil in blood were also determined by HPLC.RESULTS The RSD of intra day and inter day were less than 3%.The serum concentration curves fitted the two compartment model. The main parameters were as follows: T 1/2α was ( 0.48 ± 0.09) h , T 1/2β was ( 3.55 ± 0.27) h , T max was ( 0.79 ± 0.06) h , C max was ( 3.53 ± 0.05) mg ·L -1 ,AUC 0~∞ was ( 14.32 ± 0.30) mg .The actual value and expectant result was anastomotic elementally. CONCLUSIONS The distribution of modafinil in rats is fast, the elimination is slow.
出处 《中国医院药学杂志》 CAS CSCD 北大核心 2004年第4期195-197,共3页 Chinese Journal of Hospital Pharmacy
关键词 莫达非尼 药动学 高效液相色谱法 modafinil pharmacokinetics HPLC
  • 相关文献

参考文献10

  • 1刘萍.发作性睡眠病治疗药 莫达非尼(Modafinil)[J].国外医药(合成药.生化药.制剂分册),1999,20(4):217-217. 被引量:5
  • 2Nancy W, Peter K. Single-dose pharmacokinetics of modafinil and ethylphenidate given alone or in combination in healthy male volunteers[J] .J Clin Phamaacol, 1998, 38(5) :276.
  • 3Fuxe K, Rambert FA. Preclinical studies with modafinil: evidence for vigilance enhancement and neumprotection [J ]. Drugs Today, 1996, 32(4):313.
  • 4Gorman SH. A reverse-phase HPLC assay for the determination of d-and l-modafinil in human plasma[J]. Pharm res, 1995, 12(s):22.
  • 5倪冲,缪玉山.新型中枢精神兴奋药——莫达非尼[J].中国新药与临床杂志,2001,20(1):68-70. 被引量:9
  • 6张均田.现代药理学试验方法[M](第1版)[M].北京:北京医科大学中国协和医科大学联合出版社,1998.356.
  • 7Nancy W,Peter K. Single-dose pharmacokinetics of modafinil and ethylphenidate given alone or in combination in healthy male volunteers[J].J Clin Pharmacol,1998, 38(5):276.
  • 8Fuxe K, Rambert FA. Preclinical studies with modafinil: evidence for vigilance enhancement and neuroprotection[J]. Drugs Today, 1996, 32(4):313.
  • 9Gorman SH. A reverse-phase HPLC assay for the determination of d-and l-modafinil in human plasma[J]. Pharm res, 1995,12(s):22.
  • 10张均田.现代药理学试验方法(第1版)[M].北京:北京医科大学中国协和医科大学联合出版社,1998.356.

二级参考文献1

  • 1Wong Y N,J Clin Pharmacol,1998年,38卷,276页

共引文献11

同被引文献30

  • 1王淑惠,葛盛秋.民用航空医学进展──美国航空航天医学会第65届年会论文简介[J].中华航空医学杂志,1994,5(4X):242-245. 被引量:2
  • 2苑隆国,李电东.新型中枢兴奋药莫达非尼[J].中国新药杂志,2006,15(2):149-151. 被引量:12
  • 3LAB L, LAFON SA (FRANCE). Modafinil [ J ]. Drugs Future,1990,15(1) :130.
  • 4ENGBER TM, DENNIS SA, JONES BE, et al. Brain regional substrates for the actions of the novel wake-promoting agent modafinil in the rat: comparison with amphetamine[J] . Neuroscience, 1998, 87(4):905-911.
  • 5L1N JS, HOU Y, JOUVER M. Potential brain neuronal targets for amphetamine-, methylphenidate-, and modafinil-induced wakefulness, evidence by c-fos immunocytochemistry in the cat[J]. Proc NatI Acad Sci USA , 1996,93(24) :14128-14133.
  • 6HOU YP, LIN ,IS. Effects of modafinil and amphetamine on sleep-wake cycle after sleep deprivation in cats[ J ]. Aeta Pharmacol Sin, 1999,20(9) :813 - 818.
  • 7ROBERTSON P, DECORY HH,MADAN A,et al. In vitro inhibition and induction of human hepatic cytochrome P450 enzymes by modafinil[ J ]. Drug Metab Dispos, 2000, 33 (3) :664 - 671.
  • 8BERTZ RJ, GRANNEMAN GR. Use of in vitro and its vivo data to estimate the likelihood of metabolic pharmacokinetic interactions[J]. Clin Pharmacokinet, 1997. 32(2) :210 -258.
  • 9MOACHON G, KANMACHER 1, CLENET M,et al. Pharmacokinetic profile of modafinil [ J ]. Drugs Today, 1996, 32 ( Suppl ) :S327 - S337.
  • 10WONG YN, K1NG SP, LAUGHTON WB, et al. Single-dose pharmacokinetics of modafinil and methylphenidate given alone or in combination in healthy male volunteers [ J ]. J Clin Pharmacol, 1998, 38(3) :276 -282.

引证文献2

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部